| Literature DB >> 34068037 |
Anisa Sarah Khan1, Karla Georges1, Saed Rahaman2, Woubit Abebe3, Abiodun Adewale Adesiyun1,4.
Abstract
This cross-sectional study determined the prevalence, characteristics, and risk factors for contamination of chicken with Salmonella at four operating broiler processing plants in Trinidad. Standard methods were used to isolate and characterize the Salmonella isolates. The overall prevalence of Salmonella at the four processing plants was 27.0% (107/396). The whole carcass enrichment (WCE) method yielded a statistically significantly (p = 0.0014) higher frequency of isolation (53.9%; 97/180) than the whole carcass rinse (35.0%; 63/180) and neck skin methods (42.2%; 38/90). S. enterica serotypes Enteritidis, Javiana, and Infantis were the predominant serotypes isolated accounting for 20.8%, 16.7% and 12.5%, respectively, of the serotyped isolates. Risk factors included the use of over 100 contract farmers (OR 4.4), pre-chiller (OR 2.3), addition of chlorine to chiller (OR 3.2), slaughtering sick broilers (OR 4.4), and flocks with >50% mortality. Multi-drug resistance was detected in 12.3% (14/114) of the isolates of Salmonella. Resistance was high to kanamycin (85.7%) and doxycycline (74.6%) but low to amoxicillin-clavulanic acid (2.4%) and sulphamethoxazole-trimethoprim (0.8%). The occurrence of resistant Salmonella in chickens processed at commercial broiler processing plants has implications for salmonellosis and therapeutic failure in consumers of improperly cooked contaminated chickens from these plants in the country.Entities:
Keywords: Salmonella; Trinidad; antimicrobial resistance; broiler processing plants; risk factors; serotypes
Year: 2021 PMID: 34068037 PMCID: PMC8152471 DOI: 10.3390/microorganisms9051048
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Management and production data from four broiler processing plants in Trinidad.
| Parameter | Processing Plant: | |||
|---|---|---|---|---|
| Plant A | Plant B | Plant C | Plant D | |
| Total installed capacity of the processing plant (birds/week) | 160,000 | 250,000 | <100,000 | 100,000 |
| Average number of broilers processed daily | 32,000 | 50,000 | 15,000 | 20,000 |
| Number of days operational weekly | 5 | 5 | 4 | 5 |
| Average number of contract farmers used | 210 | 32 | 32 | 100 |
| Number of workers directly involved in Processing a | 150 | 400 | 75 | 150 |
| Number of workers indirectly involved in Processing b | 100 | 1000 | 1000 | 75 |
| Waiting period (h) between arrival of birds at plant and slaughter | 2–6 | 0.5–3 | 1–3 | 12 |
| Average mortalities (%) or broilers dead on arrival at plant | 0.7 | 0.02 | 0.94 | 0.50 |
| Disposal of solid waste (fecal materials) from broilers | Rendered c | External Company | Rendered | Rendered |
| Disposal of waste-water | River | Settling ponds | Settling ponds | Settling ponds |
| Treatment of water at the plant d | No | Yes | No | No |
a Workers who have contact with the birds/carcass at one point during processing; b Workers involved in the management of the plant but not having contact with the birds/carcass during processing; c Rendering (in-house) to convert animal tissue waste to useable by-product meal; d All plants utilized municipal water supply as their source.
Figure 1Recovery of Salmonella based on the method used.
Risk factors associated with Salmonella contamination of carcasses.
| Risk Factor | Total No. Samples Tested | Total No. (%) Positive for | Odds Ratio | CI (95%) | |
|---|---|---|---|---|---|
| Size of plant a | |||||
| Small | 44 | 5 (11.4) | Ref | ||
| Medium | 176 | 70 (39.8) | 5.1 | 1.94–13.71 | |
| Large | 176 | 32 (18.2) | 1.7 | 0.63–4.74 | |
| Average number of contract farmers | |||||
| ≤100 farmers | 308 | 61 (19.8) | Ref | ||
| >100 farmers | 88 | 46 (52.3) | 4.43 | 2.68–7.34 | |
| Number of workers directly involved in processing operation | |||||
| ≤150 workers | 220 | 75 (34.1) | Ref | ||
| >150 workers | 176 | 32 (18.2) | 0.43 | 0.27–0.70 | |
| Average waiting period from arrival at plant to processing | |||||
| ≤10 h | 308 | 83 (26.9) | Ref | ||
| >10 h | 88 | 24 (27.3) | 1.01 | 0.60–1.73 | |
| Average mortality rate (%) of birds on arrival at plant | |||||
| <0.50 | 176 | 32 (18.2) | Ref | ||
| ≥0.50 | 220 | 75 (34.1) | 2.32 | 1.45–3.74 | |
| Handling of sick/diseased birds | |||||
| Rejected at farm | 308 | 61 (19.8) | Ref | ||
| Processed last | 88 | 46 (52.3) | 4.43 | 2.68–7.34 | |
| Use of pre-chiller | |||||
| Yes | 220 | 75 (34.1) | Ref | ||
| No | 176 | 32 (18.2) | 2.32 | 1.45–3.74 | |
| Agents used in pre-chiller b | |||||
| Citric acid + chlorine | 88 | 24 (27.3) | Ref | ||
| No agents added | 132 | 51 (38.6) | 1.67 | 0.94–3.02 | |
| Temperature of pre-chiller b | |||||
| Room temperature | 88 | 46 (52.3) | Ref | ||
| 10 °C | 44 | 5 (11.4) | 0.11 | 0.04–0.33 | |
| 20 °C | 88 | 24 (27.3) | 0.34 | 0.18–0.64 | |
| Agents used in chiller | |||||
| Chlorine | 352 | 102 (29.0) | 3.18 | 1.22–8.30 | |
| No agents added c | 44 | 5 (11.4) | Ref | ||
| Concentration of chlorine used in chiller c | |||||
| 20 ppm | 88 | 24 (27.3) | Ref | ||
| 21–50 ppm | 264 | 78 (29.5) | 1.11 | 0.65–1.92 | |
| Temperature of chiller | |||||
| <1 °C | 132 | 29 (22.0) | Ref | ||
| 1–4 °C | 264 | 78 (29.5) | 1.49 | 0.91–2.43 | |
| Agents used for general cleaning of plant during processing | |||||
| Sanitizer | 352 | 102 (29.0) | Ref | ||
| Hot water only | 44 | 5 (11.4) | 0.31 | 0.12–0.82 | |
| Worker segregation d | |||||
| Yes | 352 | 102 (29.0) | 3.18 | 1.22–8.30 | |
| No | 44 | 5 (11.4) | Ref | ||
a Based on weekly throughput, small <100,000 birds; medium 101,000–160,000 birds; large >161,000 birds. b Only 3 plants use pre-chillers. c Only 3 plants add additional chlorine to chiller water. Chlorine concentration ranged from 1–5 ppm in the municipal water supply. d Colour coding of workers was done to limit movement of workers to prevent cross contamination of dirty and clean work areas.
Results of a multivariate logistic regression of risk factors for Salmonella isolation from carcasses sampled at broiler processing plants in Trinidad.
| Variable | Coef. | Standard Error a | Chi-Square | Odds Ratio | 95.0% CI | ||
|---|---|---|---|---|---|---|---|
| Lower | Upper | ||||||
|
| 2.145 | 0.521 | 16.968 | <0.001 | 8.543 | 3.078 | 23.707 |
|
| 0.55 | 0.514 | 1.147 | 0.284 | 1.733 | 0.633 | 4.744 |
|
| 1.073 | 0.532 | 4.072 | 0.044 | 2.925 | 1.031 | 8.296 |
|
| −2.054 | 0.475 | 18.7 | <0.001 | 0.128 | ||
a Standard error of the coefficient.
Frequency of isolation of Salmonella by type of samples tested at each plant.
| Stage in Processing | Type of Sample Collected | Plant A | Plant B | Plant C | Plant D | Total No. Tested | Total No. (%) Positive for | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of Samples Tested | No. (%) Positive | No. of Samples Tested | No. (%) Positive | No. of Samples Tested | No. (%) Positive | No. of Samples Tested | No. (%) Positive | ||||
| Pre-evisceration | Cloacal swab | 20 | 2 (10.0) | 40 | 0 (0.0) | 10 | 0 (0.0) | 20 | 0 (0.0) | 90 | 2 (2.2) |
| De-feathered carcass | 10 | 7 (70.0) | 20 | 9 (45.0) | 5 | 1 (20.0) | 10 | 6 (60.0) | 45 | 23 (51.1) | |
| 0.002 | <0.001 | 0.333 | 0.0004 | <0.001 | |||||||
| Subtotal | 30 | 9 (30.0) | 60 | 9 (30.0) | 15 | 1 (6.7) | 30 | 6 (20.0) | 135 | 25 (18.5) | |
| Post-evisceration | Eviscerated carcass | 10 | 7 (70.0) | 20 | 5 (25.0) | 5 | 0 (0.0) | 10 | 5 (50.0) | 45 | 17 (37.8) |
| Neck skin | 20 | 14 (70.0) | 40 | 9 (22.5) | 10 | 0 (0.0) | 20 | 2 (10.0) | 90 | 25 (27.8) | |
| 0.656 | 0.535 | NA | 0.026 | 0.972 | |||||||
| Subtotal | 30 | 21 (70.0) | 60 | 14 (23.3) | 15 | 0 (0.0) | 30 | 7 (23.3) | 135 | 42 (31.1) | |
| Chiller water and carcasses | Chilled water | 8 | 0 (0.0) | 16 | 2 (12.5) | 4 | 0 (0.0) | 8 | 0 (0.0) | 36 | 2 (5.6) |
| Chilled-whole carcass | 10 | 7 (70.0) | 20 | 5 (25.0) | 5 | 3 (60.0) | 10 | 5 (50.0) | 45 | 20 (44.4) | |
| Chilled-parts | 10 | 9 (90.0) | 20 | 2 (10.0) | 5 | 1 (20.0) | 10 | 6 (60.0) | 45 | 18 (40.0) | |
| 0.0004 | 0.391 | 0.123 | 0.024 | 0.0003 | |||||||
| Subtotal | 28 | 16 (57.1) | 56 | 9 (16.1) | 14 | 4 (28.6) | 28 | 11 (39.3) | 126 | 40 (31.7) | |
| Total | 88 | 46 (52.3) | 176 | 32 (18.2) | 44 | 5 (11.4) | 88 | 24 (27.3) | 396 | 107 (27.0) | |
| <0.001 | |||||||||||
| Pre-evisceration | 30 | 9 (30.0) | 60 | 9 (30.0) | 15 | 1 (6.7) | 30 | 6 (20.0) | 135 | 25 (18.5) | |
| Post-evisceration | 30 | 21 (70.0) | 60 | 14 (23.3) | 15 | 0 (0.0) | 30 | 7 (23.3) | 135 | 42 (31.1) | |
| Chiller water and carcasses | 28 | 16 (57.1) | 56 | 9 (16.1) | 14 | 4 (28.6) | 28 | 11 (39.3) | 126 | 40 (31.7) | |
| 0.007 | 0.439 | 0.041 | 0.215 | 0.023 | |||||||
Salmonella serotypes isolated from different types of samples.
| Stage of Processing | No. of Samples Positive for | No. (%) a of Isolates Serotyped | Serotypes (No., %) |
|---|---|---|---|
| Cloacal swabs | 2 | 0 (0.0) | Not applicable |
| Pre-evisceration carcass | 23 | 2 (8.7) | Weltevreden (1, 50.0) |
| Enteritidis (1, 50.0) | |||
| Post-evisceration carcass | 17 | 5 (29.4) | Javiana (3, 60.0) |
| Virchow (1, 20.0) | |||
| Infantis (1, 20.0) | |||
| Neck skins | 25 | 25 (100.0) | Javiana (7, 28.0) |
| Schwarzengrund (5, 20.0) | |||
| Albany (4, 16.0) | |||
| Anatum (3, 12.0) | |||
| Infantis (2, 8.0) | |||
| Group C2 b (2, 8.0) | |||
| Madjorio (1, 4.0) | |||
| Enteritidis (1, 4.0) | |||
| Chiller water | 2 | 2 (100.0) | |
| subspecies Houtenae IV (1, 50.0) | |||
| Chilled whole carcass | 20 | 20 (100.0) | Enteritidis (7, 35.0) |
| Infantis (4, 20.0) | |||
| Anatum (2, 10.0) | |||
| Albany (1, 5.0) | |||
| Mbandaka (1, 5.0) | |||
| Schwarzengrund (1, 5.0) | |||
| Aberdeen (1, 5.0) | |||
| Javiana (1, 5.0) | |||
| Kentucky (1, 5.0) | |||
| Ayinde (1, 5.0) | |||
| Chilled chicken parts | 18 | 18 (100.0) | Enteritidis (6, 33.3) |
| Kentucky (6, 33.3) | |||
| Infantis (2, 11.1) | |||
| Hindmarsh (1, 5.6) | |||
| Javiana (1, 5.6) | |||
| Anatum (1, 5.6) | |||
| Alachua (1, 5.6) | |||
| Total | 107 | 72 (67.3) |
a Of the number of randomly selected Salmonella serotypes from each source; b Serogroup (Group C2) could not be determined to the serotype level.
Figure 2Antimicrobial resistance of Salmonella isolates isolated from four processing plants. * AMC, amoxicillin-clavulanic acid (30 µg); DO, doxycycline (30 µg); CRO, ceftriaxone (30 µg); CN, gentamicin (10 µg); K, kanamycin (30 µg); C, chloramphenicol (30 µg); SXT, sulfamethoxazole-trimethoprim (23.75 and 1.25 µg); CIP, ciprofloxacin (5 µg).
Antimicrobial resistance of Salmonella isolated from various stages of processing.
| Stage in Processing | Type of Sample Collected | No. of Isolates Tested | No. (%) of Isolates Resistant a | No. (%) Resistant to b: | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMC | DO | CRO | CN | K | C | SXT | CIP | ||||
| Pre-evisceration | Cloacal swab | 3 | 3 (100.0) | 0 (0.0) | 1 (33.3) | 0 (0.0) | 1 (33.3) | 3 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Defeathered carcass | 25 | 24 (96.0) | 0 (0.0) | 23 (92.0) | 1 (4.0) | 2 (8.0) | 23 (92.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| 1 | NA | 0.045 | 1 | 0.298 | 1 | NA | NA | NA | |||
| Subtotal | 28 | 27 (96.4) | 0 (0.0) | 24 (85.7) | 1 (3.6) | 3 (10.7) | 26 (92.9) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Post-evisceration | Eviscerated Carcass | 17 | 15 (88.2) | 0 (0.0) | 12 (70.6) | 0 (0.0) | 2 (11.8) | 14 (82.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Neck skin | 25 | 23 (92.0) | 0 (0.0) | 18 (72.0) | 2 (8.0) | 6 (24.0) | 21 (84.0) | 0 (0.0) | 0 (0.0) | 3 (12.0) | |
| 1 | NA | 1 | 0.506 | 0.439 | 1 | NA | NA | 0.260 | |||
| Subtotal | 42 | 38 (90.5) | 0 (0.0) | 30 (71.4) | 2 (4.8) | 8 (19.0) | 35 (83.3) | 0 (0.0) | 0 (0.0) | 3 (7.1) | |
| Chiller water and carcasses | Chiller water | 2 | 2 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (100.0) | 0 (0.0) | 0 (0.0) | 1 (50.0) |
| Chilled-whole carcass | 29 | 25 (86.2) | 0 (0.0) | 20 (69.0) | 4 (13.8) | 4 (13.8) | 24 (82.8) | 0 (0.0) | 0 (0.0) | 2 (6.9) | |
| Chilled-parts | 25 | 22 (88.0) | 3 (12.0) | 20 (80.0) | 2 (8.0) | 0 (0.0) | 21 (84.0) | 1 (4.0) | 1 (4.0) | 0 (0.0) | |
| 0.846 | 0.140 | 0.050 | 0.698 | 0.135 | 0.814 | 0.532 | 0.532 | 0.009 | |||
| Subtotal | 56 | 49 (87.5) | 3 (5.4) | 40 (71.4) | 6 (10.7) | 4 (7.1) | 47 (83.9) | 1 (1.8) | 1 (1.8) | 3 (5.4) | |
| Total | 126c | 114 (90.5) | 3 (2.4) | 94 (74.6) | 9 (7.1) | 15 (11.9) | 108 (85.7) | 1 (0.8) | 1 (0.8) | 6 (4.8) | |
| Pre-evisceration | 28 | 27 (96.4) | 0 (0.0) | 24 (85.7) | 1 (3.6) | 3 (10.7) | 26 (92.9) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Post-evisceration | 42 | 38 (90.5) | 0 (0.0) | 30 (71.4) | 2 (4.8) | 8 (19.0) | 35 (83.3) | 0 (0.0) | 0 (0.0) | 3 (7.1) | |
| Chiller water and carcasses | 56 | 49 (87.5) | 3 (5.4) | 40 (71.4) | 6 (10.7) | 4 (7.1) | 47 (83.9) | 1 (1.8) | 1 (1.8) | 3 (5.4) | |
| 0.422 | 0.147 | 0.310 | 0.373 | 0.193 | 0.471 | 0.533 | 0.533 | 0.374 | |||
a Resistance to one or more agents tested. b AMC, amoxicillin-clavulanic acid (30 µg); DO, doxycycline (30 µg); CRO, ceftriaxone (30 µg); CN, gentamicin (10 µg); K, kanamycin (30 µg); C, chloramphenicol (30 µg); SXT, sulfamethoxazole-trimethoprim (23.75 and 1.25 µg); CIP, ciprofloxacin (5 µg). c A total of 126 isolates may have included duplicates of isolates obtained from TT/XLT-4, TT/BGA, RVS/XLT-4, and RVS/BGA media, solely of phenotypes. NA: Not applicable.
Resistance exhibited by different serotypes isolated at four processing plants.
| Serotype a | No. of Isolates Tested | No. (%) of Isolates Resistant b | No. (%) Isolates Resistant to c: | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AMC | DO | CRO | CN | K | C | SXT | CIP | |||
| Albany | 5 | 5 (100.0) | 0 (0.0) | 5 (100.0) | 2 (40.0) | 0 (0.0) | 4 (80.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Anatum | 6 | 6 (100.0) | 0 (0.0) | 6 (100.0) | 2 (33.3) | 0 (0.0) | 4 (66.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Enteritidis | 15 | 9 (60.0) | 1 (6.7) | 1 (6.7) | 0 (0.0) | 0 (0.0) | 9 (60.0) | 1 (6.7) | 0 (0.0) | 2 (13.3) |
| Infantis | 9 | 8 (88.9) | 0 (0.0) | 6 (66.7) | 0 (0.0) | 2 (22.2) | 8 (88.9) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Javiana | 12 | 10 (83.3) | 0 (0.0) | 10 (83.3) | 0 (0.0) | 4 (33.3) | 10 (83.3) | 0 (0.0) | 0 (0.0) | 3 (25.0) |
| Kentucky | 7 | 7 (100.0) | 2 (28.6) | 7 (100.0) | 1 (14.3) | 0 (0.0) | 6 (85.7) | 0 (0.0) | 1 (14.3) | 0 (0.0) |
| Schwarzengrund | 6 | 5 (83.3) | 0 (0.0) | 4 (66.7) | 0 (0.0) | 2 (33.3) | 5 (83.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| 0.813 | <0.001 | 0.252 | 0.238 | 0.745 | 1 | 0.996 | 0.192 | |||
| Total | 60 | 50 (83.3) | 3 (5.0) | 39 (65.0) | 5 (8.3) | 8 (13.3) | 46 (76.7) | 1 (1.7) | 1 (1.7) | 5 (8.3) |
a In addition, 2 (100.0%) of 2 Group C2 isolates exhibited resistance to one or more of the eight antimicrobial agents tested; 1 (100.0%) of 1 of the following serotypes Aberdeen, Alachua, Ayinde, Hindmarsh, Madjorio, Mbandaka, Salmonella sp. (untypable), S. Houtenae, Virchow, and Weltevreden were resistant, i.e., a total of 12 isolates. b Exhibited resistance to one or more antimicrobial agents. c AMC, amoxicillin-clavulanic acid (30 µg); DO, doxycycline (30 µg); CRO, ceftriaxone (30 µg); CN, gentamicin (10 µg); K, kanamycin (30 µg); C, chloramphenicol (30 µg); SXT, sulfamethoxazole-trimethoprim (23.75 and 1.25 µg); CIP, ciprofloxacin (5 µg).